This is the general protocol for both preventative measures, and also if you or someone you know gets covid. this has been investigated and proven by hundreds of doctors with THOUSANDS of their patients over the last 1.5 years, including 200+ million indians, japanese, africans and others.
This is a flow chart to help understand when it might be time to add to your treatments.
This one kind of lists everything that could work, the 2nd and 3rd graphs get a little convoluded with so much info, but the first one really has much of everything you need.
Your core daily preventatives should be Quercetin - 250 to 500 mg daily (helps the D3 & Zinc Penetrate the cells deeper)
Vit D3 (with vit K1&2) - 125 mcg daily (look for a multi pill, K keeps D3 from calcifying in your arteries) Zinc - 25 a day (do not go higher than 25 or 30 for a prolonged period, can damage liver?) Vit C - 1000mg daily
below is Dr. Zelenko's home website, his protocol is essentially listed above in the graphs.
Melatonin Significantly Reduces Covid-19 Mortality
STORY AT-A-GLANCE
While most well-known as a natural sleep regulator, melatonin also has many other important functions. It boosts immune function, helps recharge glutathione and may improve treatment of certain bacterial diseases; it has anticonvulsant and antiexcitotoxic properties, and is a potent antioxidant with the rare ability to enter your mitochondria
In viral infections, melatonin lowers the overreaction of the host cells to the pathogen, thereby raising the host’s tolerance to the virus. This gives the host time to develop the adaptive immune response and eradicate the invading pathogen
Melatonin attenuates several pathological features of COVID-19, including excessive oxidative stress and inflammation, exaggerated immune response resulting in a cytokine storm, acute lung injury and acute respiratory distress syndrome
An October 2021 study found melatonin significantly lowered mortality when given to severely infected COVID patients. In the standard care only group, 13 of the 76 patients died (17.1%), compared to just one of the 82 patients (1.2%) who received melatonin in addition to standard care — a reduction in mortality of 93%
During the second week of infection, a time when severely infected patients can take a drastic turn for the worse, the melatonin group fared much better than the standard care only group, with only two patients developing sepsis, compared to eight in the standard care only group